Report Detail

Other Global Insomnia Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3369566
  • |
  • 01 May, 2019
  • |
  • Global
  • |
  • 137 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Scope of the Report:
The worldwide market for Insomnia Therapy is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Insomnia Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck & Co. Inc.
Sanofi
Pfizer, Inc.
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare Inc.
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Non-pharmacological Therapy
Pharmacological Therapy

Market Segment by Applications, can be divided into
Hospital
Ambulatory Surgical Center
Home Care

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insomnia Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insomnia Therapy, with price, sales, revenue and global market share of Insomnia Therapy in 2017 and 2018.
Chapter 3, the Insomnia Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insomnia Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insomnia Therapy market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insomnia Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Insomnia Therapy Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Non-pharmacological Therapy
      • 1.2.2 Pharmacological Therapy
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Ambulatory Surgical Center
      • 1.3.3 Home Care
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Merck & Co. Inc.
      • 2.1.1 Business Overview
      • 2.1.2 Insomnia Therapy Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck & Co. Inc. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 Insomnia Therapy Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Pfizer, Inc.
      • 2.3.1 Business Overview
      • 2.3.2 Insomnia Therapy Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Pfizer, Inc. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Takeda Pharmaceutical Company Ltd.
      • 2.4.1 Business Overview
      • 2.4.2 Insomnia Therapy Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Purdue Pharmaceuticals L.P.
      • 2.5.1 Business Overview
      • 2.5.2 Insomnia Therapy Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Eisai, Co. Ltd.
      • 2.6.1 Business Overview
      • 2.6.2 Insomnia Therapy Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Eisai, Co. Ltd. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Meda Consumer Healthcare Inc.
      • 2.7.1 Business Overview
      • 2.7.2 Insomnia Therapy Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Pernix Therapeutics
      • 2.8.1 Business Overview
      • 2.8.2 Insomnia Therapy Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Pernix Therapeutics Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Vanda Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 Insomnia Therapy Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Vanda Pharmaceuticals Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 ECR Pharmaceuticals
      • 2.10.1 Business Overview
      • 2.10.2 Insomnia Therapy Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 ECR Pharmaceuticals Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Fidia Farmaceutici
      • 2.11.1 Business Overview
      • 2.11.2 Insomnia Therapy Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Fidia Farmaceutici Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Dainippon Sumitomo
      • 2.12.1 Business Overview
      • 2.12.2 Insomnia Therapy Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Dainippon Sumitomo Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Biocodex
      • 2.13.1 Business Overview
      • 2.13.2 Insomnia Therapy Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Biocodex Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Eli Lilly and Company
      • 2.14.1 Business Overview
      • 2.14.2 Insomnia Therapy Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Eli Lilly and Company Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Ebb Therapeutics
      • 2.15.1 Business Overview
      • 2.15.2 Insomnia Therapy Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Ebb Therapeutics Insomnia Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Insomnia Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Insomnia Therapy Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Insomnia Therapy Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Insomnia Therapy Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Insomnia Therapy Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Insomnia Therapy Market Analysis by Regions

    • 4.1 Global Insomnia Therapy Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Insomnia Therapy Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Insomnia Therapy Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 4.3 Europe Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 4.5 South America Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Insomnia Therapy Sales and Growth Rate (2014-2019)

    5 North America Insomnia Therapy by Country

    • 5.1 North America Insomnia Therapy Sales, Revenue and Market Share by Country
      • 5.1.1 North America Insomnia Therapy Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Insomnia Therapy Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 5.3 Canada Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Insomnia Therapy Sales and Growth Rate (2014-2019)

    6 Europe Insomnia Therapy by Country

    • 6.1 Europe Insomnia Therapy Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Insomnia Therapy Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Insomnia Therapy Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 6.3 UK Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 6.4 France Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 6.5 Russia Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 6.6 Italy Insomnia Therapy Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Insomnia Therapy by Country

    • 7.1 Asia-Pacific Insomnia Therapy Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Insomnia Therapy Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Insomnia Therapy Revenue and Market Share by Country (2014-2019)
    • 7.2 China Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 7.3 Japan Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 7.4 Korea Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 7.5 India Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Insomnia Therapy Sales and Growth Rate (2014-2019)

    8 South America Insomnia Therapy by Country

    • 8.1 South America Insomnia Therapy Sales, Revenue and Market Share by Country
      • 8.1.1 South America Insomnia Therapy Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Insomnia Therapy Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Insomnia Therapy Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Insomnia Therapy by Countries

    • 9.1 Middle East and Africa Insomnia Therapy Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Insomnia Therapy Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Insomnia Therapy Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Insomnia Therapy Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Insomnia Therapy Sales and Growth Rate (2014-2019)

    10 Global Insomnia Therapy Market Segment by Type

    • 10.1 Global Insomnia Therapy Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Insomnia Therapy Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Insomnia Therapy Revenue and Market Share by Type (2014-2019)
    • 10.2 Non-pharmacological Therapy Sales Growth and Price
      • 10.2.1 Global Non-pharmacological Therapy Sales Growth (2014-2019)
      • 10.2.2 Global Non-pharmacological Therapy Price (2014-2019)
    • 10.3 Pharmacological Therapy Sales Growth and Price
      • 10.3.1 Global Pharmacological Therapy Sales Growth (2014-2019)
      • 10.3.2 Global Pharmacological Therapy Price (2014-2019)

    11 Global Insomnia Therapy Market Segment by Application

    • 11.1 Global Insomnia Therapy Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Ambulatory Surgical Center Sales Growth (2014-2019)
    • 11.4 Home Care Sales Growth (2014-2019)

    12 Insomnia Therapy Market Forecast (2019-2024)

    • 12.1 Global Insomnia Therapy Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Insomnia Therapy Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Insomnia Therapy Market Forecast (2019-2024)
      • 12.2.2 Europe Insomnia Therapy Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Insomnia Therapy Market Forecast (2019-2024)
      • 12.2.4 South America Insomnia Therapy Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Insomnia Therapy Market Forecast (2019-2024)
    • 12.3 Insomnia Therapy Market Forecast by Type (2019-2024)
      • 12.3.1 Global Insomnia Therapy Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Insomnia Therapy Market Share Forecast by Type (2019-2024)
    • 12.4 Insomnia Therapy Market Forecast by Application (2019-2024)
      • 12.4.1 Global Insomnia Therapy Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Insomnia Therapy Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Insomnia Therapy. Industry analysis & Market Report on Insomnia Therapy is a syndicated market report, published as Global Insomnia Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Insomnia Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,777.04
      4,165.56
      5,554.08
      3,246.84
      4,870.26
      6,493.68
      535,084.80
      802,627.20
      1,070,169.60
      290,440.80
      435,661.20
      580,881.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report